Endocrine Agents

53

Transcript of Endocrine Agents

Page 1: Endocrine Agents
Page 2: Endocrine Agents
Page 3: Endocrine Agents

Growth Hormone (GH)2 Hormones Regulate GH 1. Growth hormone-releasing hormone (GN-RH) 2. Growth hormone-inhibiting hormone (GN-IH)

* NOT given orally given thru SQ or IM

* Can cause DM

Page 4: Endocrine Agents

Deficiency of GH

somatrem (Protropin)somatropin (Humatrope) – C/I for pedia patients

with growth deficiency due to Prader Willi syndrome, severely obese, severe respiratory impairment

Promotes bone growth at epiphyseal plates of long bones

Page 5: Endocrine Agents

Excess of GH

Gigantism – during childhoodAcromegaly – after puberty

* Due to GH hypersecretion or pituitary tumor

bromocriptine mesylate (Parlodel) – inhibits the release of GH from pituitary

octreotide (Sandostatin) – also used for severe diarrhea due to carcinoid tumor

Page 6: Endocrine Agents

Thyroid-Stimulating Hormone (TSH)Releases thyroxine (T4) and triiodothyronine (T3)

Excess TSH – HyperthyroidismDeficit TSH – Hypothyroidism. Maybe caused by

thyroid gland disorder (primary) or decrease in TSH secretion (secondary)

thyrotropin (Thyropar) – purified extract of TSH used to diagnose primary and secondary hypothyroidism

Page 7: Endocrine Agents

Adrenocorticotropic hormone (ACTH) Stimulates the release of the ff:

1. glucocorticoids (cortisol)2. mineralocorticoids (aldosterone)3. androgen* follows diurnal rythmn

corticotropin (Acthar) given IV or IM Agent in the diagnosis of adrenal gland disorder Used in the treatment of adrenal gland

insufficiency Suppresses inflammatory and immune response

Page 8: Endocrine Agents

secretes Antidiuretic Hormone/Vasopressin AND Oxytocin

ADH promotes water reabsorptionADH deficit leads to Diabetes Insipidus

desmopressin (DDAVP – desmopressin acetate)vasopressin (Pitressin)Given intranasally or injection

Page 9: Endocrine Agents

Nursing ProcessAssessment:1. Determine urinary output and weight2. Assess for infectious process3. Compare child’s growth with standards

Diagnosis:Ineffective health maintenanceDelayed growth and development

Interventions:ADH Monitor V/S, increase HR, decrease systolic

pressure (hypovolemia)

Page 10: Endocrine Agents

ACTH Observe client’s weight for possible edema.

Side effect is sodium and water retention Taper dose Electrolyte monitoring

GH Monitor blood sugar and electrolyte levels

(possible hyperglycemia)

Page 11: Endocrine Agents

THYROID GLANDSThyroid hormones stimulate metabolism and cardiac

function, and are essential for normal growth and development of the nervous and musculoskeletal systems.

Hypothyroidism is the abnormally decreased secretion of thyroid hormone.

Page 12: Endocrine Agents

Caused by: Primary cause (thyroid gland disorder) Secondary cause (lack of TSH secretion)

Cretinism is hypothyroidism in infants.

Unless treated early, the infant will be short in stature and delayed in mental and physical development.

Page 13: Endocrine Agents

Myxedema is hypothyroidism in adults.

Manifestations: bradycardia, cold and dry skin, brittle hair, low

body temperature, fatigue, cold intolerance, flat affect, slowed cognition, and weight gain

Page 14: Endocrine Agents

Drug Therapy:

Levothyroxine (Synthroid, Levothroid), the most commonly used replacement

- used to treat simple goiter and chronic lymphocytic (Hashimoto) thyroiditis

Liothyronine (Cytomel), synthetic T3, useful in treating Myxedema Coma, better absorbed from GI, NOT for maintenance therapy

Page 15: Endocrine Agents

Liotrix (Euthroid, Thyrolar)Mixture of levothyroxine sodium and liothyronine

sodium in 4:1 ratio

Page 16: Endocrine Agents

Antithyroid Agents Hyperthyroidism is the abnormal increase secretion of thyroid hormone. Grave’s disease/thyrotoxicosis

- common Manifestations:

tachycardia, dysrhythmias, palpitations, excessive perspiration, heat intolerance, nervousness, irritability, exopthalmos, weight loss

*** can be treated by surgery

Page 17: Endocrine Agents

Thyroid crisis (or “storm”) characterized by hyperthermia, tachycardia, and profound weakness, behavioral changes

Drug Therapy: Thiourea derivatives (Thioamides) – drug of choice.

Blocks thyroid hormone2 thioamides:

propylthiouracil (PTU) - Inhibit peripheral conversion of T4 to T3methimazole (Tapazole) – 10 times more potent, with longer half-life

Page 18: Endocrine Agents

Iodide preparations have been used to suppress thyroid function for those who have undergone subtotal thyroidectomy.

strong iodine solution (Lugol’s solution, Potassium iodide solution)

SE: teeth discoloration

Page 19: Endocrine Agents

Nursing ProcessAssessment1. Assess serum T3, T4, and TSH levels

2. Drug history because of drug-drug interactions like oral anticoagulants, digoxin, insulin, oral hypoglycemics,

3. Assess for signs of thyroid crisis

Page 20: Endocrine Agents

Client health teaching:

For hypothyroidism-Take drug same time each day, pre-breakfast-To report signs of hyperthyroidism-Avoid foods that can inhibit thyroid

secretions(strawberry, peach, pear, cabbage, cauliflower, radish, peas)

Page 21: Endocrine Agents

For hyperthyroidism-Taken with meals-Avoid iodine and iodine-containing food, OTC

cough meds-Do not discontinue abruptly-Avoid the drugs if pregnant or breastfeeding

Page 22: Endocrine Agents

Parathyroid Glands

Parathyroid hormone (PTH) regulates calcium levels in the blood.

Decrease in serum calcium stimulates the release of PTHCalcitonin decreases serum calcium

PTH agents treat hypoparathyroidism Synthetic calcitonin is used for decreasing serum

calcium levels (hyperparathyroidism)

Page 23: Endocrine Agents

Hypoparathyroidism and Hypocalcemia Agentscalcitriol (Rocaltrol) – Increases serum calcium with

long onset of action.calcifediol (Calderol) – bone disease and

hypocalcemia associated with chronic renal disease and dialysis

Hyperparathyroidism and Hypercalcemia Agentscalcitonin (human) (Cibacalcin) – Paget’s diseasecalcitonin (salmon) (Calcimar)

Page 24: Endocrine Agents
Page 25: Endocrine Agents

Nursing Process

Assessment Assess for symptoms of tetany in hypocalcemia:

twitching of the mouth, tingling and numbness of the fingers, carpopedal and laryngeal and carpopedal spasm

Page 26: Endocrine Agents

Interventions1. Monitor serum Ca levels (reference is 8.5-

10.5 mg/dl)

2. Client teaching: Report signs of tetany and hypercalcemia

(bone pain, anorexia, N/V, thirst, constipation, lethargy, bradycardia, polyuria)

Check OTC drugs

Page 27: Endocrine Agents

Adrenal GlandsAdrenal cortex produces two hormones or

corticosteroids: glucocorticoids (cortisol) and mineralocorticoids (aldosterone)

It affects carbohydrate, protein and fat metabolism; Na retention and water reabsorption and K excretion; have antinflammatory, antiallergic, and anti-stress effects

Addison’s disease- decrease in corticosteroidCushing’s syndrome - increase in corticosteroid

Page 28: Endocrine Agents

Addison’s disease: weight loss, fatigue, hyperpigmentation, muscle weakness, low blood pressure

Page 29: Endocrine Agents
Page 30: Endocrine Agents

1. Glucocorticoids Short-acting cortisone acetate (Cortone Acetate) hydrocortisone (Cortef, Hydrocortone)

Intermediate-actingmethylprednisolone (Medrol, Solu-Medrol)prednisolone (Hydeltrasol) prednisone (Deltasone)

Page 31: Endocrine Agents

Long-actingbetamethasone (Celestone)dexamethasone (Decadron)

2. Glucocorticoid InhibitorsUsed in treating clients with Cushing’s syndrome

ketoconazole (Nizoral)aminogluthethimide (Cytadren)Mitotane (Lysodren) – ANTINEOPLASTIC hormone

antagonist

Page 32: Endocrine Agents

3. Mineralocorticoids (aldosterone)Secrete aldosterone that maintain fluid balance

fludrocortisone (Florinef) – oral mineralocorticoid

Page 33: Endocrine Agents

Nursing ProcessAssessment1. Monitor electrolyte (hypokalemia) ana blood sugar2. Obtain weight and urine outputInterventions1. Watch out for increase in BP2. Report weight gain of 5 lbs in several days3. Encourage foods high in potassium4. Taper the dose:5. Taken with meals

Page 34: Endocrine Agents

Blood glucose is regulated by insulin. Responsible for:

◦Facilitating the passage of glucose into cells for energy

◦Suppressing excess production of sugar in the liver and muscles

◦Suppressing the breakdown of fat for energy

Page 35: Endocrine Agents

ANTIDIABETIC AGENTS

Two Major Classes of Drugs: Insulins Oral Hypoglycemic Agents

These agents can be used as monotherapy in the treatment of type 2 diabetes

May be used in combination therapy with insulin in the treatment of type 1 diabetes

Page 36: Endocrine Agents

INSULINS INSULINS

Two Main Sources:Two Main Sources:Domesticated animals Domesticated animals Recombinant DNA technologyRecombinant DNA technology

Page 37: Endocrine Agents
Page 38: Endocrine Agents

Activity Classification Brand RAPID-ACTING Humalog

lisproSHORT-ACTING Humulin R,

regular

INTERMEDIATE-ACTINGNPH insulinHumulin NLente insulinHumulin L insulin

Page 39: Endocrine Agents

LONG-ACTING-Ultralente insulin-Lantus

CombinationsHumulin 70/30 – isophane NPH 70%, regular 30%Humulin 50/50 – isophane NPH 50%, regular 50%

Page 40: Endocrine Agents

InsulinTypes: Onset Peak DurationRapid-acting 5 min 0.5-1 hr 2-4 hrs

Short-acting 0.5-1 hr 2-4 hrs 6-8 hrs

Intermediate-acting 1-2 hrs 6-12 hrs 18-24 hrs

Long-acting 5-8 hrs 14-20 hrs 30-36 hrs

Premixed Insulin- 0.5 hour 4-8 hrs 22-24 hrs

Page 41: Endocrine Agents

Complications of Insulin Administration: Allergic reactions Insulin lipodystrophy(lipoatrophy, lipohypertrophy) Insulin resistance Somogyi and Dawn phenomenon

Easier Administration:Insulin pen injectorsInsulin pumpsInsulin jet injectors

Page 42: Endocrine Agents
Page 43: Endocrine Agents
Page 44: Endocrine Agents

Interventions:Avoid extremes in temperature when storing insulinBefore injection, insulin should be at room

temperatureInjection sites are abdomen, arms, thighs, and hipsDon’t use same site more than once in a 2- 3 week

period

Page 45: Endocrine Agents

Use a syringe with a matched calibration of units to the insulin concentration

1-2 week supply of insulin may be preparedRegular insulin firstREGULAR INSULIN THE ONLY ONE THAT CAN BE

GIVEN IV

Page 46: Endocrine Agents

Oral Antidiabetic Drugs

First and Second-Generation Sulfonylureas- Stimulate pancreatic beta cells to secrete more

insulin

First Generation1. Short-acting

tolbutamide (Orinase)2. Intermediate-acting

acetohexamide (Dymelor)tolazamide (Tolinase)

Page 47: Endocrine Agents

3. Long-actingchlorpropamide (Diabinese)

Second Generation- Increase tissue response to insulin, decrease

glucose production of the liverGlimepiride (Amaryl), glipizide (Glucotrol)

Page 48: Endocrine Agents

Non-Sulfonylureas

1. BIGUANIDES Reduces hepatic production of glucose by inhibiting

glycogenolysis; decreasing intestinal absorption of glucose; and improving lipid profile.

metformin (Glucophage)

Page 49: Endocrine Agents

2. ALPHA-GLUCOSIDASE INHIBITORS Inhibits alpha-glucosidase enzymes in the small

intestine and alpha-amylase in the pancreas. The result is reduced rate of glucose absorption postprandially.

acarbose (Precose)miglitol (Glyset)

Page 50: Endocrine Agents

3. THIAZOLIDINEDIONES Functions primarily by enhancing insulin action at

the receptor sites and decreases insulin resistance

rosiglitazone (Avandia)

4. MEGLITINIDE Also increases insulin secretion.

repaglinide (Prandin)nateglinide (Starlix)

Page 51: Endocrine Agents

5. Incretin Modifier Increase level of incretin hormones, increase

insulin secretion, decrease glucagon secretion to reduce glucose production

sitaglipitin phosphate (Januvia)

Page 52: Endocrine Agents

Nursing ProcessAssessment1. Note blood sugar levels2. Determine knowledge of DM and oral

antidiabeticsIntervention1. Teach symptoms of hypoglycemia2. Insulin might be needed during stress,

surgery, or serious infection3. No alcohol, no skipping/delaying meals

Page 53: Endocrine Agents

Hyperglycemic Agents

Glucagon – stimulates glycogen breakdown- Available parenteral use (SC, IM, IV)

diazoxide (Proglycem, Hyperstat)- inhibits insulin release- parenteral form